206 related articles for article (PubMed ID: 16184420)
1. Antiulcer drugs and gastric cancer.
Waldum HL; Gustafsson B; Fossmark R; Qvigstad G
Dig Dis Sci; 2005 Oct; 50 Suppl 1():S39-44. PubMed ID: 16184420
[TBL] [Abstract][Full Text] [Related]
2. Does long-term profound inhibition of gastric acid secretion increase the risk of ECL cell-derived tumors in man?
Waldum HL; Hauso Ø; Brenna E; Qvigstad G; Fossmark R
Scand J Gastroenterol; 2016 Jul; 51(7):767-73. PubMed ID: 26872579
[TBL] [Abstract][Full Text] [Related]
3. Hypergastrinemia and gastric enterochromaffin-like cells.
Bordi C; D'Adda T; Azzoni C; Pilato FP; Caruana P
Am J Surg Pathol; 1995; 19 Suppl 1():S8-19. PubMed ID: 7762739
[TBL] [Abstract][Full Text] [Related]
4. Physiological and clinical significance of enterochromaffin-like cell activation in the regulation of gastric acid secretion.
Cui G; Waldum HL
World J Gastroenterol; 2007 Jan; 13(4):493-6. PubMed ID: 17278212
[TBL] [Abstract][Full Text] [Related]
5. The regulation of gastric acid secretion - clinical perspectives.
Waldum HL; Hauso Ø; Fossmark R
Acta Physiol (Oxf); 2014 Feb; 210(2):239-56. PubMed ID: 24279703
[TBL] [Abstract][Full Text] [Related]
6. Gastrin-physiological and pathophysiological role: clinical consequences.
Waldum HL; Brenna E; Kleveland PM; Sandvik AK
Dig Dis; 1995; 13(1):25-38. PubMed ID: 7606834
[TBL] [Abstract][Full Text] [Related]
7. Gastric carcinoids after long-term use of a proton pump inhibitor.
Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
[TBL] [Abstract][Full Text] [Related]
8. Omeprazole: its influence on gastric acid secretion, gastrin and ECL cells.
Larsson H; Håkanson R; Mattsson H; Ryberg B; Sundler F; Carlsson E
Toxicol Pathol; 1988; 16(2):267-72. PubMed ID: 3187355
[TBL] [Abstract][Full Text] [Related]
9. The consequences of hypergastrinemia.
Creutzfeldt W
Yale J Biol Med; 1994; 67(3-4):181-94. PubMed ID: 7502528
[TBL] [Abstract][Full Text] [Related]
10. [Antisecretory drugs, hypergastrinemia and hyperplasia of enterochromaffin-like cells (ECL)].
Andriulli A; Mangia A; Lawson F
Minerva Gastroenterol Dietol; 1991; 37(3):135-40. PubMed ID: 1686409
[TBL] [Abstract][Full Text] [Related]
11. Histamine metabolism of gastric carcinoids in Mastomys natalensis.
Kölby L; Wängberg B; Ahlman H; Modlin IM; Nilsson O
Yale J Biol Med; 1998; 71(3-4):207-15. PubMed ID: 10461353
[TBL] [Abstract][Full Text] [Related]
12. Changes in gastric ECL cells and parietal cells after long-term administration of high-dose omeprazole to patients with Barrett's esophagus.
Nishi T; Makuuchi H; Weinstein WM
Tokai J Exp Clin Med; 2005 Jul; 30(2):117-21. PubMed ID: 16146202
[TBL] [Abstract][Full Text] [Related]
13. Acid suppression and gastric mucosal cell biology.
Delle Fave G; Helander H; Holt S; Modlin IM; Powers R; Solcia E; Soll A; Tielemans Y; Wright NA
Dig Dis Sci; 1994 Sep; 39(9):1843-52. PubMed ID: 8082489
[TBL] [Abstract][Full Text] [Related]
14. Relationship of ECL cells and gastric neoplasia.
Waldum HL; Brenna E; Sandvik AK
Yale J Biol Med; 1998; 71(3-4):325-35. PubMed ID: 10461363
[TBL] [Abstract][Full Text] [Related]
15. [Enterochromaffin-like cells and their receptors: physiological role and physiopathological significance].
Belaiche J; Delwaide J; Louis E; Gast P
Acta Gastroenterol Belg; 1993; 56(3-4):235-44. PubMed ID: 7505515
[TBL] [Abstract][Full Text] [Related]
16. Gastric ECL-cell hyperplasia and carcinoids in rodents following chronic administration of H2-antagonists SK&F 93479 and oxmetidine and omeprazole.
Betton GR; Dormer CS; Wells T; Pert P; Price CA; Buckley P
Toxicol Pathol; 1988; 16(2):288-98. PubMed ID: 2903544
[TBL] [Abstract][Full Text] [Related]
17. Personal review: is profound acid inhibition safe?
Waldum HL; Brenna E
Aliment Pharmacol Ther; 2000 Jan; 14(1):15-22. PubMed ID: 10632641
[TBL] [Abstract][Full Text] [Related]
18. Considerations for long-term use of proton-pump inhibitors.
Garnett WR
Am J Health Syst Pharm; 1998 Nov; 55(21):2268-79. PubMed ID: 9825878
[TBL] [Abstract][Full Text] [Related]
19. Proposed mechanism of induction of gastric carcinoids: the gastrin hypothesis.
Håkanson R; Sundler F
Eur J Clin Invest; 1990 Oct; 20 Suppl 1():S65-71. PubMed ID: 2125000
[TBL] [Abstract][Full Text] [Related]
20. The peroxisome-proliferator ciprofibrate induces hypergastrinemia without raising gastric pH.
Martinsen TC; Nesjan N; Rønning K; Sandvik AK; Waldum HL
Carcinogenesis; 1996 Oct; 17(10):2153-5. PubMed ID: 8895482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
